Jian Li

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Eye Diseases, Hereditary, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, albinism, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, hereditary disease, hereditary skin disorder, hypopigmentation of the skin, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, neoplasm, piebaldism, skin disorder, skin pigmentation disorder	Recruiting	Phase 2	2026-04-30		NCT07559864
JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Active, not recruiting	Phase 1	2026-01-08		NCT06838338

Clinical trials